242 related articles for article (PubMed ID: 34070642)
1. Molecular Elucidation of a Urate Oxidase from
Chiu YC; Hsu TS; Huang CY; Hsu CH
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070642
[TBL] [Abstract][Full Text] [Related]
2. Structural and biochemical insights into a hyperthermostable urate oxidase from Thermobispora bispora for hyperuricemia and gout therapy.
Chiu YC; Hsu TS; Huang CY; Hsu CH
Int J Biol Macromol; 2021 Oct; 188():914-923. PubMed ID: 34403675
[TBL] [Abstract][Full Text] [Related]
3. PEG-uricase in the management of treatment-resistant gout and hyperuricemia.
Sherman MR; Saifer MG; Perez-Ruiz F
Adv Drug Deliv Rev; 2008 Jan; 60(1):59-68. PubMed ID: 17826865
[TBL] [Abstract][Full Text] [Related]
4. Serum uric acid-lowering therapies: where are we heading in management of hyperuricemia and the potential role of uricase.
Bomalaski JS; Clark MA
Curr Rheumatol Rep; 2004 Jun; 6(3):240-7. PubMed ID: 15134605
[TBL] [Abstract][Full Text] [Related]
5. Control of hyperuricemia in subjects with refractory gout, and induction of antibody against poly(ethylene glycol) (PEG), in a phase I trial of subcutaneous PEGylated urate oxidase.
Ganson NJ; Kelly SJ; Scarlett E; Sundy JS; Hershfield MS
Arthritis Res Ther; 2006; 8(1):R12. PubMed ID: 16356199
[TBL] [Abstract][Full Text] [Related]
6. Rationalization design, soluble expression and PEG modification of highly active recombinant human-porcine uricase mutant protein.
Tong M; Wang S; Luan J; Xie Q; Wang L; Shen X; Xiong S
Int J Biol Macromol; 2024 Jun; 269(Pt 1):131989. PubMed ID: 38697425
[TBL] [Abstract][Full Text] [Related]
7. [Rasburicase (Fasturtec)].
Vogt B; Gugger M; Frey FJ
Ther Umsch; 2004 Sep; 61(9):579-82. PubMed ID: 15493120
[TBL] [Abstract][Full Text] [Related]
8. Expression, localization and metabolic function of "resurrected" human urate oxidase in human hepatocytes.
Duan Y; Jiang N; Chen J; Chen J
Int J Biol Macromol; 2021 Apr; 175():30-39. PubMed ID: 33513422
[TBL] [Abstract][Full Text] [Related]
9. Rasburicase represents a new tool for hyperuricemia in tumor lysis syndrome and in gout.
Cammalleri L; Malaguarnera M
Int J Med Sci; 2007 Mar; 4(2):83-93. PubMed ID: 17396159
[TBL] [Abstract][Full Text] [Related]
10. Learning how and when to employ uricase as bridge therapy in refractory gout.
Terkeltaub R
J Rheumatol; 2007 Oct; 34(10):1955-8. PubMed ID: 17924606
[No Abstract] [Full Text] [Related]
11. A Therapeutic Uricase with Reduced Immunogenicity Risk and Improved Development Properties.
Nyborg AC; Ward C; Zacco A; Chacko B; Grinberg L; Geoghegan JC; Bean R; Wendeler M; Bartnik F; O'Connor E; Gruia F; Iyer V; Feng H; Roy V; Berge M; Miner JN; Wilson DM; Zhou D; Nicholson S; Wilker C; Wu CY; Wilson S; Jermutus L; Wu H; Owen DA; Osbourn J; Coats S; Baca M
PLoS One; 2016; 11(12):e0167935. PubMed ID: 28002433
[TBL] [Abstract][Full Text] [Related]
12. [Gout: an overview of available urate lowering therapies].
Richette P
Ann Pharm Fr; 2012 May; 70(3):133-8. PubMed ID: 22655581
[TBL] [Abstract][Full Text] [Related]
13. Recent approaches to gout drug discovery: an update.
Otani N; Ouchi M; Kudo H; Tsuruoka S; Hisatome I; Anzai N
Expert Opin Drug Discov; 2020 Aug; 15(8):943-954. PubMed ID: 32329387
[TBL] [Abstract][Full Text] [Related]
14. Urate oxidase (rasburicase) for treatment of severe acute gout: a case report.
Wipfler-Freibmuth E; Dejaco C; Duftner C; Gaugg M; Kriessmayr-Lungkofler M; Schirmer M
Clin Exp Rheumatol; 2009; 27(4):658-60. PubMed ID: 19772802
[TBL] [Abstract][Full Text] [Related]
15. Diabetes insipidus in uricase-deficient mice: a model for evaluating therapy with poly(ethylene glycol)-modified uricase.
Kelly SJ; Delnomdedieu M; Oliverio MI; Williams LD; Saifer MGP; Sherman MR; Coffman TM; Johnson GA; Hershfield MS
J Am Soc Nephrol; 2001 May; 12(5):1001-1009. PubMed ID: 11316859
[TBL] [Abstract][Full Text] [Related]
16. Urate crystal degradation for treatment of gout: a nanoparticulate combination therapy approach.
Tiwari S; Dwivedi H; Kymonil KM; Saraf SA
Drug Deliv Transl Res; 2015 Jun; 5(3):219-30. PubMed ID: 25787730
[TBL] [Abstract][Full Text] [Related]
17. Arxula adeninivorans recombinant urate oxidase and its application in the production of food with low uric acid content.
Trautwein-Schult A; Jankowska D; Cordes A; Hoferichter P; Klein C; Matros A; Mock HP; Baronian K; Bode R; Kunze G
J Mol Microbiol Biotechnol; 2013; 23(6):418-30. PubMed ID: 24022585
[TBL] [Abstract][Full Text] [Related]
18. Directed evolution to improve the catalytic efficiency of urate oxidase from Bacillus subtilis.
Li W; Xu S; Zhang B; Zhu Y; Hua Y; Kong X; Sun L; Hong J
PLoS One; 2017; 12(5):e0177877. PubMed ID: 28531234
[TBL] [Abstract][Full Text] [Related]
19. Pegloticase for treating refractory chronic gout.
George RL; Sundy JS
Drugs Today (Barc); 2012 Jul; 48(7):441-9. PubMed ID: 22844655
[TBL] [Abstract][Full Text] [Related]
20. Engineered
Zhao R; Li Z; Sun Y; Ge W; Wang M; Liu H; Xun L; Xia Y
Gut Microbes; 2022; 14(1):2070391. PubMed ID: 35491895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
